Skip to navigation bar Skip to breadcrumbs Skip to page content
clear place holder
Envelope icon E-mail Updates Teal square Text size:  a A A

Clinical Summary

Hepatitis B in Pregnant Women: Screening

Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.

Clinical Summary of U.S. Preventive Services Task Force Recommendation

This document is a summary of the 2009 recommendation of the U.S. Preventive Services Task force on screening for Hepatitis B infection in pregnancy. It is intended for use by primary care clinicians. This summary was first published in Annals of Internal Medicine in June 2009 (Ann Intern Med 2009;150:871; http://www.annals.org).

Population All Pregnant Women
Recommendation Screen at the first prenatal visit.
Grade: A
Screening Tests

Serologic identification of hepatitis B surface antigen (HBsAg).

Reported sensitivity and specificity are greater than 98%.

Timing of Screening

Order HBsAg testing at the first prenatal visit.

Re-screen women with unknown HBsAg status or new or continuing risk factors at admission to hospital, birth center, or other delivery setting.

Interventions

Administer hepatitis B vaccine and hepatitis B immune globulin to HBV-exposed infants within 12 hours of birth.

Refer women who test positive for counseling and medical management. 
Counseling should include information about how to prevent transmission to sexual partners and household contacts. 

Reassure patients that breastfeeding is safe for infants who receive appropriate prophylaxis.

Implementation
Establish systems for timely transfer of maternal HBsAg test results to the labor and delivery and newborn medical records.
Relevant USPSTF Recommendations
USPSTF recommendations on the screening of pregnant women for other infections, including asymptomatic bacteriuria, bacterial vaginosis, chlamydia, HIV, and syphilis, can be found athttp://www.uspreventiveservicestaskforce.org.

For a summary of the evidence systematically reviewed in making these recommendations, the full recommendation statement, and supporting documents, please go tohttp://www.uspreventiveservicestaskforce.org.

Disclaimer: Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.

Copyright and Source Information

This document is in the public domain within the United States.

Requests for linking or to incorporate content in electronic resources should be sent via the USPSTF contact form.

Current as of: June 2009

Internet Citation: Clinical Summary: Hepatitis B in Pregnant Women: Screening. U.S. Preventive Services Task Force. June 2016.
https://www.uspreventiveservicestaskforce.org/Page/Document/ClinicalSummaryFinal/hepatitis-b-in-pregnant-women-screening

USPSTF Program Office   5600 Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857